Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia
Junya Kuroda(Kyoto Prefectural University of Medicine), T Maekawa(Kyoto University Hospital)
Cited by 65
Related Papers
AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model
|Blood Cancer Journal|2011|49
Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in a hypoxic environment
|Cell Death and Differentiation|2010|38
p53‐independent anti‐tumor effects of the nitrogen‐containing bisphosphonate zoledronic acid
|Cancer Science|2004|37
BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic Approach
|Cancer Genomics & Proteomics|2019|18